Skip to main content
Top
Published in: Clinical Rheumatology 10/2008

01-10-2008 | Original Article

The autonomic dysfunction in patients with ankylosing spondylitis: a clinical and electrophysiological study

Authors: Pinar Borman, Figen Gokoglu, Seher Kocaoglu, Z. Rezan Yorgancioglu

Published in: Clinical Rheumatology | Issue 10/2008

Login to get access

Abstract

The aim of this study was to determine autonomic nervous system (ANS) functions by using clinical and electrophysiological tests in patients with ankylosing spondylitis (AS). Twenty AS and 20 healthy control subjects were recruited. Demographic data, symptoms related with ANS, and neurological findings were recorded. Clinical measurements including the heart rate variation with deep breathing (HRV), heart rate response to standing (HRS), systolic blood pressure response to standing, and diastolic blood pressure response to isometric exercise were obtained to assess parasympathetic and sympathetic functions of the subjects. The electrophysiological assessments of ANS were performed by sympathetic skin response (SSR) and R–R interval variation (RRIV) measurements for the sympathetic and parasympathetic functions, respectively. Patients with AS were subdivided into two groups depending on the activity of disease. The difference between the groups and relationship between ANS variables and clinical entities were determined. Fifteen male and five female AS patients with a mean age of 38 ± 8.05 years and 14 male and six female healthy control subjects with a mean age of 40 ± 9.8 years were included in the study. All the subjects were totally symptom free for ANS involvement and had normal neurological examination findings. The levels of HRV, HRS, and the mean RRIV values were significantly lower in AS patients than in control subjects. The clinical ANS parameters of the patients having more active disease were lower than in subjects with mild disease in regard to HRV values and SSR amplitudes and higher in regard to SSR latencies. The HRV values were found to be correlated with the mean scores of Bath ankylosing spondylitis disease activity index (BASDAI) and C-reactive protein (CRP) levels, and the mean latencies of SSR were correlated with BASDAI scores and CRP levels. In conclusion, our study indicates a subclinical mainly parasympathetic dysfunction of ANS in patients with AS which can be related with disease activity.
Literature
1.
go back to reference Vander Linden S, Van Der Heijde, Brawn J (2005) Ankylosing spondylitis. In: Harris ED, Budd RC, Firestern GS et al (eds) Kelley’s textbook of rheumatology, 7th edn. Saunders, Philadelphia, pp 1125–1139 Vander Linden S, Van Der Heijde, Brawn J (2005) Ankylosing spondylitis. In: Harris ED, Budd RC, Firestern GS et al (eds) Kelley’s textbook of rheumatology, 7th edn. Saunders, Philadelphia, pp 1125–1139
2.
go back to reference O’Neill TW, Bresnihan B (2005) The heart in ankylosing spondylitis. Ann Rheum Dis 51:705–706CrossRef O’Neill TW, Bresnihan B (2005) The heart in ankylosing spondylitis. Ann Rheum Dis 51:705–706CrossRef
3.
go back to reference Tyrell PNM, Davies AM, Evans N (1994) Neurological disturbances in ankylosing spondylitis. Ann Rheum Dis 53:714CrossRef Tyrell PNM, Davies AM, Evans N (1994) Neurological disturbances in ankylosing spondylitis. Ann Rheum Dis 53:714CrossRef
4.
go back to reference Pillay N, Hunter T (1986) Delayed evoked potentials in patients with ankylosing spondylitis. J Rheumatol 13:137–141PubMed Pillay N, Hunter T (1986) Delayed evoked potentials in patients with ankylosing spondylitis. J Rheumatol 13:137–141PubMed
5.
go back to reference Toussirot E, Bouhaddi MB, Poncet JC et al (1999) Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis 58:481–487PubMed Toussirot E, Bouhaddi MB, Poncet JC et al (1999) Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis 58:481–487PubMed
6.
go back to reference Yildirir A, Aksoyek S, Calguneri M et al (2001) No evidence of cardiac autonomic involvement in ankylosing spondylitis, as assessed by heart rate variability. Clin Rheumatol 20:185–188PubMedCrossRef Yildirir A, Aksoyek S, Calguneri M et al (2001) No evidence of cardiac autonomic involvement in ankylosing spondylitis, as assessed by heart rate variability. Clin Rheumatol 20:185–188PubMedCrossRef
7.
go back to reference Ozgocmen S, Yoldas T, Yigiter R et al (2006) R–R interval variation and sympathetic skin response in fibromyalgia. Arch Med Res 37:630–634PubMedCrossRef Ozgocmen S, Yoldas T, Yigiter R et al (2006) R–R interval variation and sympathetic skin response in fibromyalgia. Arch Med Res 37:630–634PubMedCrossRef
8.
go back to reference Sandhu V, Allen SC (2004) The effects of age, seropositivity and disease duration on autonomic cardiovascular reflexes in patients with rheumatoid arthritis. Int J Clin Pract 58:740–745PubMedCrossRef Sandhu V, Allen SC (2004) The effects of age, seropositivity and disease duration on autonomic cardiovascular reflexes in patients with rheumatoid arthritis. Int J Clin Pract 58:740–745PubMedCrossRef
9.
go back to reference Evrengül H, Dursunoglu D, Cobankara V et al (2004) Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 24:198–202PubMedCrossRef Evrengül H, Dursunoglu D, Cobankara V et al (2004) Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 24:198–202PubMedCrossRef
10.
go back to reference Karatas GK, Önder M, Meray J (2002) Autonomic nervous system involvement in Behçet’s disease. Rheumatol Int 22:155–159PubMedCrossRef Karatas GK, Önder M, Meray J (2002) Autonomic nervous system involvement in Behçet’s disease. Rheumatol Int 22:155–159PubMedCrossRef
11.
go back to reference McLeod JG (1999) Evaluation of the autonomic nervous system. In: Aminoff MJ (ed) Electrodiagnosis in clinical neurology. 4th edn. Elsevier, Amsterdam, pp 421–432 McLeod JG (1999) Evaluation of the autonomic nervous system. In: Aminoff MJ (ed) Electrodiagnosis in clinical neurology. 4th edn. Elsevier, Amsterdam, pp 421–432
12.
go back to reference Vander Linden S, Volkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRef Vander Linden S, Volkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRef
13.
go back to reference Garret S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis; the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291 Garret S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis; the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291
14.
go back to reference Küçükdeveci AA, McKenna SP, Kutlay S et al (2000) The development and psychometric assessment of the Turkish version of the Nottingham health profile. Int J Rehabil Res 23:31–38PubMedCrossRef Küçükdeveci AA, McKenna SP, Kutlay S et al (2000) The development and psychometric assessment of the Turkish version of the Nottingham health profile. Int J Rehabil Res 23:31–38PubMedCrossRef
15.
go back to reference Shahani BT, Day TJ, Cros D et al (1990) R–R interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy. Arch Neurol 47:659–664PubMed Shahani BT, Day TJ, Cros D et al (1990) R–R interval variation and the sympathetic skin response in the assessment of autonomic function in peripheral neuropathy. Arch Neurol 47:659–664PubMed
16.
go back to reference Shahani BT, Halperin JJ, Boulu P et al (1994) Sympathetic skin response. A method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neurol Neurosurg Psychiatry 47:536–542 Shahani BT, Halperin JJ, Boulu P et al (1994) Sympathetic skin response. A method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neurol Neurosurg Psychiatry 47:536–542
17.
go back to reference Shoemaker JK, Hogeman CS, Khan M et al (2001) Gender affects sympathetic and hemodynamic response to postural stress. Am J Physiol Heart Circ Physiol 281:H2028–H2035PubMed Shoemaker JK, Hogeman CS, Khan M et al (2001) Gender affects sympathetic and hemodynamic response to postural stress. Am J Physiol Heart Circ Physiol 281:H2028–H2035PubMed
18.
go back to reference Jones PP, Spraul M, Matt KS et al (1996) Gender does not influence sympathetic neural reactivity to stress in healthy humans. Am J Physiol Heart Circ Physiol 270:H350–H357 Jones PP, Spraul M, Matt KS et al (1996) Gender does not influence sympathetic neural reactivity to stress in healthy humans. Am J Physiol Heart Circ Physiol 270:H350–H357
19.
go back to reference Dart AM, Du XJ, Kingwell BA (2002) Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res 53:678–687PubMedCrossRef Dart AM, Du XJ, Kingwell BA (2002) Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res 53:678–687PubMedCrossRef
20.
go back to reference Piha SJ, Voipio-Pulkki L-M (1993) Elevated resting heart rate in rheumatoid arthritis: possible role of deconditioning. Br J Rheum 32:212–215CrossRef Piha SJ, Voipio-Pulkki L-M (1993) Elevated resting heart rate in rheumatoid arthritis: possible role of deconditioning. Br J Rheum 32:212–215CrossRef
21.
go back to reference Tan J, Akin S, Beyazova M et al (1993) Sympathetic skin response and R–R interval variation in rheumatoid arthritis. Am J Phys Med Rehabil 72:196–203PubMedCrossRef Tan J, Akin S, Beyazova M et al (1993) Sympathetic skin response and R–R interval variation in rheumatoid arthritis. Am J Phys Med Rehabil 72:196–203PubMedCrossRef
22.
go back to reference Gamez-Nava JI, Gonzalez-Lopez L, Ramos Remus C et al (1998) Autonomic dysfunction in patients with systemic lupus erythematosus. J Rheumatol 25:1092–1096PubMed Gamez-Nava JI, Gonzalez-Lopez L, Ramos Remus C et al (1998) Autonomic dysfunction in patients with systemic lupus erythematosus. J Rheumatol 25:1092–1096PubMed
23.
go back to reference Dekkers JC, Geenen R, Godaert GLR et al (2004) Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 22:63–70PubMed Dekkers JC, Geenen R, Godaert GLR et al (2004) Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 22:63–70PubMed
24.
25.
go back to reference Shahabi S, Hassan ZM, Jazani NH et al (2006) Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med Hypotheses 67:900–903PubMedCrossRef Shahabi S, Hassan ZM, Jazani NH et al (2006) Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med Hypotheses 67:900–903PubMedCrossRef
26.
go back to reference Goldstein RS, Bruchfeld A, Yang L et al (2007) Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13:210–215PubMedCrossRef Goldstein RS, Bruchfeld A, Yang L et al (2007) Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13:210–215PubMedCrossRef
Metadata
Title
The autonomic dysfunction in patients with ankylosing spondylitis: a clinical and electrophysiological study
Authors
Pinar Borman
Figen Gokoglu
Seher Kocaoglu
Z. Rezan Yorgancioglu
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 10/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0906-0

Other articles of this Issue 10/2008

Clinical Rheumatology 10/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine